Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT05874557
Eligibility Criteria:
Inclusion Criteria:
* Patients who received maintenance hemodialysis (≥ 3 months) in Renji Hospital;
* Regularly participate in the routine laboratory examination of the hemodialysis center every 3 months;
* Inclusion criteria of the treatment group: regular treatment with compound amino acid capsule for 9 months (2 tablets, 3 times a day, orally);
* Inclusion criteria of the control group: no compound amino acid capsules or similar nutritional supplement were taken.
Exclusion Criteria:
* Severe heart failure (NYHA III/IV);
* Human immunodeficiency virus positive or is suffering from other serious infectious diseases;
* Have a history of malignant tumor;
* Women during pregnancy or lactation;
* Exclusion criteria for treatment group: previous use of amino acids or compound ketoacid supplement
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05874557
Study Brief:
Protocol Section:
NCT05874557